DeepMed Research

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device

Not Applicable

Completed

Conditions: Tear, Pelvic Organ, Obstetric Trauma

Interventions: Device: Materna Medical

First Posted Date: 2015-01-07

Last Posted Date: 2020-08-06

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 61

Registration Number: NCT02332759

Locations: 🇺🇸
Texas Children's Hospital Pavilion For Women, Houston, Texas, United States

Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi

Not Applicable

Completed

Conditions: Preterm Birth
Periodontal Disease
Caries, Dental

Interventions: Dietary Supplement: Xylitol gum

First Posted Date: 2015-01-07

Last Posted Date: 2024-01-08

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10069

Registration Number: NCT02333227

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Tranexamic Acid in Adherent Placenta (TAP)

Phase 3

Withdrawn

Conditions: Placenta Accreta

Interventions: Drug: Tranexamic Acid (TXA)
Drug: Sodium Chloride 0.9%

First Posted Date: 2015-01-01

Last Posted Date: 2018-08-23

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT02329756

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Standardized Prenatal Clinical Care for LUTO

Recruiting

Conditions: Urethral Obstruction

Interventions: Procedure: Fetal Intervention for LUTO

First Posted Date: 2014-12-12

Last Posted Date: 2024-10-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 50

Registration Number: NCT02315521

Locations: 🇺🇸
Texas Children's Hospital - Pavilion for Women, Houston, Texas, United States

DOXAZOSIN FOR PTSD

Phase 1

Completed

Conditions: PTSD

Interventions: Drug: doxazosin
Drug: Placebo
Drug: Perindopril

First Posted Date: 2014-12-04

Last Posted Date: 2022-04-26

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 30

Registration Number: NCT02308202

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Biological: TAA-specific CTLs- fixed dose
Biological: TAA-specific CTLs

First Posted Date: 2014-11-17

Last Posted Date: 2025-01-31

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 36

Registration Number: NCT02291848

Locations: 🇺🇸
Harris Health Smith Clinic, Houston, Texas, United States
🇺🇸
Harris Health Ben Taub Hospital, Houston, Texas, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States

Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)

Phase 1

Active, not recruiting

Conditions: Hodgkin Disease
Nasopharyngeal Carcinoma
Non-Hodgkin Lymphoma
Severe Chronic Active Epstein Barr Virus
T/NK-lymphoproliferative Disease
Smooth Muscle Tumor

Interventions: Biological: MABEL CTLs
Drug: Cyclophosphamide
Drug: Fludarabine

First Posted Date: 2014-11-10

Last Posted Date: 2025-02-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 38

Registration Number: NCT02287311

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Multicenter Evaluation of Memory Remediation After TBI With Donepezil

Phase 3

Completed

Conditions: Memory Deficits
Traumatic Brain Injury

Interventions: Drug: Placebo
Drug: Donepezil

First Posted Date: 2014-10-03

Last Posted Date: 2025-01-15

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 75

Registration Number: NCT02255799

Locations: 🇺🇸
TIRR Memorial Hermann, Houston, Texas, United States
🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States

and more 1 locations

The Houston HIITBAC for African Americans

Not Applicable

Completed

Conditions: Asthma

Interventions: Other: Enhanced Clinic Care
Other: Enhanced Clinic Care + Home Intervention

First Posted Date: 2014-10-01

Last Posted Date: 2018-11-14

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 264

Registration Number: NCT02253433

Locations: 🇺🇸
Harris Health Smith Clinic, Houston, Texas, United States

Nitric Oxide Supplementation in Argininosuccinic Aciduria

Not Applicable

Completed

Conditions: Argininosuccinic Aciduria
Argininosuccinate Lyase Deficiency
Urea Cycle Disorders

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Nitric oxide supplement

First Posted Date: 2014-09-30

Last Posted Date: 2020-01-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 12

Registration Number: NCT02252770

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy